Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

846 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment.
Yamamichi G, Kato T, Arakawa N, Ino Y, Ujike T, Nakano K, Koh Y, Motoyama Y, Outani H, Myoba S, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Fukuhara S, Uemura H, Okada S, Morii E, Nonomura N, Uemura M. Yamamichi G, et al. Among authors: hatano k. Biomark Res. 2024 Nov 25;12(1):147. doi: 10.1186/s40364-024-00695-6. Biomark Res. 2024. PMID: 39587633
Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fat.
Uemura T, Kawashima A, Jingushi K, Motooka D, Saito T, Sassi N, Horibe Y, Yamamoto A, Liu Y, Tani M, Yoshimura A, Oka T, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Kato T, Hatano K, Tsujikawa K, Wada H, Nonomura N. Uemura T, et al. Among authors: hatano k. Cancer Sci. 2024 Nov 20. doi: 10.1111/cas.16410. Online ahead of print. Cancer Sci. 2024. PMID: 39566543 Free article.
PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide.
Oka T, Hatano K, Tani M, Yoshimura A, Horibe Y, Liu Y, Sassi N, Okuda Y, Yamamoto A, Uemura T, Yamamichi G, Ishizuya YU, Yamamoto Y, Kato T, Kawashima A, Fujita K, Nonomura N. Oka T, et al. Among authors: hatano k. Cancer Diagn Progn. 2024 Nov 3;4(6):706-714. doi: 10.21873/cdp.10385. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502601 Free PMC article.
T-ALL presenting with i-TLP-like indolent clinical course with repeated spontaneous regressions.
Toda Y, Ohmine K, Sano N, Nakamura N, Kihara A, Tominaga R, Noguchi A, Yokoyama D, Furuki S, Koyama S, Murahashi R, Nakashima H, Hyodo K, Kawaguchi SI, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Fujiwara SI, Kanda Y. Toda Y, et al. Among authors: hatano k. Pathol Res Pract. 2024 Nov;263:155600. doi: 10.1016/j.prp.2024.155600. Epub 2024 Sep 24. Pathol Res Pract. 2024. PMID: 39326364
Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.
Yamamoto A, Kawashima A, Sakai S, Mita M, Sassi N, Inoguchi S, Horibe Y, Yoshimura A, Tani M, Yutong L, Okuda Y, Oka T, Uemura T, Yamamichi G, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Hatano K, Kakuta Y, Imamura R, Takahara S, Kimura T, Nonomura N. Yamamoto A, et al. Among authors: hatano k. Biochem Biophys Res Commun. 2024 Nov 12;733:150701. doi: 10.1016/j.bbrc.2024.150701. Epub 2024 Sep 14. Biochem Biophys Res Commun. 2024. PMID: 39326256 Free article.
846 results